Patients with diabetes undergoing hemodialysis who initiate GLP-1 agonists have an 18% lower risk for incident dementia than ...

A new analysis suggests that people with type 2 diabetes who use GLP-1 medications like Ozempic, Trulicity or Victoza may be ...

Ozempic may have neurologic benefit despite Alzheimer's setback, large study suggests ...

GLP-1 receptor agonists are associated with a lower risk of dementia than DPP-4 inhibitors in dialysis patients with diabetes.

For an older person with type 2 diabetes, especially someone already at risk of frailty, a GLP 1 or SGLT 2 medicine, where ...

Dual therapy with metformin and GLP-1 RAs is associated with a lower risk for adiposity-related cancers and mortality than DPP-4 inhibitor therapy in patients with T2D.

A preliminary study of people with diabetes suggests that use of glucose-lowering GLP-1 drugs may be linked to a lower risk of developing epilepsy. The study was published on December 10, 2025, in ...

Popular GLP-1 medications such as Ozempic may carry an unexpected link to a lower risk of epilepsy in people with type 2 ...

GLP-1RAs and DPP-4is are associated with a higher risk for biliary disease than SGLT2is among individuals with type 2 diabetes.

GLP-1 medications have been examined for a possible additional effect in patients with type 2 diabetes.

A large US-based study has found that people with type 2 diabetes taking GLP-1 drugs such as Ozempic may be slightly less ...

A preliminary study of people with diabetes suggests that use of glucose-lowering GLP-1 drugs may be linked to a lower risk ...